This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: University of Ghent. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Glenn Verstraete: Innovator in Pharmaceutical Dosage Forms
Introduction
Glenn Verstraete is a notable inventor based in Rollegem-Kapelle, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. With a total of 3 patents to his name, Verstraete's work is recognized for its innovative approach to drug formulation.
Latest Patents
One of Glenn Verstraete's latest patents focuses on an oral dosage form that comprises one or more granules. This invention details a method for manufacturing the dosage form, where the granules are prepared using the extrusion/spheronization technique with partially hydrolysed polyvinyl alcohol. The advantage of this formulation is its ability to contain a high drug load, enhancing the efficacy of the pharmaceutical product.
Career Highlights
Verstraete is affiliated with the University of Ghent, where he continues to advance research in pharmaceutical sciences. His work has contributed to the understanding and development of effective drug delivery systems.
Collaborations
Throughout his career, Glenn Verstraete has collaborated with esteemed colleagues such as Chris Vervaet and Jean Paul Remon. These partnerships have fostered a collaborative environment that promotes innovation in pharmaceutical research.
Conclusion
Glenn Verstraete's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of effective oral dosage forms, showcasing the importance of innovation in healthcare.